RxDoctor Payments DataLook up a doctor →

Max Benzaquen, MD

Neurology · Chesterfield, MONPI 1366426900

Payments from drug & device makers

$295,746in general payments, 2019–2025

Across 3,174 payments — averaging $93.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • SK Life Science, Inc.$187K
  • AbbVie$32K
  • Lilly USA, LLC$8K
  • Biohaven Pharmaceuticals, Inc.$7K
  • Takeda Pharmaceuticals U.S.A., Inc.$7K
  • Biohaven Pharmaceutical Holding Company Ltd.$5K
  • plus $49K from 54 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
SK Life Science, Inc.109$187,078
AbbVie(2 entities)344$31,815
Lilly USA, LLC47$8,147
Biohaven Pharmaceuticals, Inc.36$7,185
Takeda Pharmaceuticals U.S.A., Inc.36$6,616
Biohaven Pharmaceutical Holding Company Ltd.22$5,002
Jazz Pharmaceuticals Inc.147$3,770
Teva Pharmaceuticals USA, Inc.131$2,780
Greenwich Biosciences, Inc.114$2,373
Lundbeck LLC70$2,235
Novartis158$2,218
Supernus Pharmaceuticals, Inc.114$2,171
UCB, Inc.127$2,106
Biogen157$2,080
Neurocrine Biosciences, Inc.86$1,860
CSL Behring64$1,841
Validus Pharmaceuticals LLC24$1,820
EMD Serono, Inc.97$1,735
AstraZeneca(2 entities)53$1,427
Sunovion Pharmaceuticals Inc.88$1,407
Acadia Pharmaceuticals Inc92$1,398
Genentech USA, Inc.54$1,279
Otsuka America Pharmaceutical, Inc.57$1,273
Pfizer104$1,170
Neurelis, Inc.57$1,058
MDD US Operations, LLC28$963
Eisai Inc.53$954
Amgen42$854
Amneal Pharmaceuticals LLC55$852
Upsher-smith Laboratories LLC40$713
Vanda Pharmaceuticals Inc.32$706
Harmony Biosciences LLC22$629
Kyowa Kirin, Inc.33$613
Argenx US, Inc.30$612
Johnson & Johnson(2 entities)33$585
Tanabe Pharma America, Inc.27$573
Arbor Pharmaceuticals, Inc.42$513
Sanofi26$500
Impel Pharmaceuticals Inc.41$442
Grifols USA, LLC19$370
Avanir Pharmaceuticals, Inc.22$323
Bristol Myers Squibb21$305
Sumitomo Pharma America, Inc.16$295
Axsome Therapeutics, Inc.11$281
E.r. Squibb & Sons, L.L.C.4$276
Scilex Pharmaceuticals Inc.14$235
GE HealthCare16$233
Catalyst Pharmaceuticals, Inc.11$216
Bausch Health US, LLC30$210
Adamas Pharmaceuticals, Inc.16$190
Banner Life Sciences, LLC14$123
Acorda Therapeutics, Inc7$122
Aprecia Pharmaceuticals, LLC10$117
Azurity Pharmaceuticals, Inc.6$92
Alnylam Pharmaceuticals Inc.6$89
Tersera Therapeutics LLC5$81
Merck5$72
Kedrion Biopharma, Inc.4$68
Avion Pharmaceuticals4$66
Promius Pharma LLC5$65

How this compares

$295,746 in reported general payments places this provider in the 90th percentile of 381 neurology providers in Missouri.

See all neurology providers in Missouri →

Medicare billing

Part B allowed, 2024
$58,971
Medicare patients
231
Services billed
1,262

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other neurology in Chesterfield

See the full list for Missouri →

Where these figures come from

Is this you, or does something look wrong? →